Research
When a tissue process changes, what has to be proven again
A claim that a process reduces disease risk has to rest on a verified or validated process. Change the process and the rules make you go back and show it still holds.
The question a marketing sentence quietly raises
A product page for a tissue-derived preparation will often say the process reduces the risk of disease transmission. Sometimes it says sterile, or names a pathogen inactivation step.
The tissue rules treat that sentence as a regulated claim rather than a description. There is a section that says what has to sit behind it.
Any written representation that processing methods reduce the risk of transmission of communicable disease, including a representation of sterility or pathogen inactivation, "must be based on a fully verified or validated process."
That single requirement is the reason the rest of this material matters. Validation is not a formality; it is the thing a claim is allowed to rest on.
When validation is required at all
Validation is not demanded of every step. The trigger is a limit on what testing can see.
Where the results of processing cannot be fully verified by subsequent inspection and tests, the process must be validated and approved according to established procedures.
That is the classic case for a sterilization or inactivation step: you cannot test every unit to destruction, so you prove the process instead.
The validation activities and results are documented, including the date and the signature of whoever approved the validation. A validation with no name on it is not what the section describes.
A change is an event with a procedure attached
Processes drift. A supplier substitution, a new machine, a shortened cycle, a different reagent — each one is a change, and the rules give changes their own section.
The requirement runs in three parts. A change must be verified or validated to ensure it does not create an adverse impact elsewhere in the operation.
It must be approved before implementation by a responsible person with appropriate knowledge and background. And approved changes must be communicated to the appropriate personnel in a timely manner.
The validation section adds the follow-through. When changes occur to a validated process, the firm must review and evaluate the process and perform revalidation where appropriate, documenting those activities.
Equipment has to be capable of producing valid results
The equipment section sets a design standard before it sets any maintenance schedule. Equipment must be of appropriate design for its use, and suitably located and installed to facilitate operations, including cleaning and maintenance.
Then a phrase worth holding onto. Any automated, mechanical, electronic or other equipment used for inspection, measuring or testing "must be capable of producing valid results."
Cleaning, sanitizing and maintenance run on established schedules, under written procedures designed to prevent malfunctions, contamination, cross-contamination and accidental exposure to disease agents.
Calibration is required where appropriate, routinely, against established procedures and schedules, for the same category of inspection, measuring and testing equipment.
The equipment record that is meant to be visible
Most records in this part live in a file. One is required to be posted.
Records of recent maintenance, cleaning, sanitizing, calibration and other activities have to be displayed on or near each piece of equipment. The alternative is making them readily available to the people responsible for those activities and to the personnel using it.
There is also a linking record. The firm must maintain records of the use of each piece of equipment, including the identification of each product manufactured with it.
That is what makes a machine-level problem traceable to specific units afterward. Without it, a fault found later has no defined blast radius.
Supplies and reagents are not trusted on arrival
Incoming materials get a gate. Supplies and reagents may not be used until they have been verified to meet specifications designed to prevent circumstances that increase disease-transmission risk.
The verification can be done by the establishment that uses the material or by the vendor. Where the vendor does it, the record kept is a certificate of analysis from the vendor.
Reagents used in processing and preservation must be sterile, where appropriate — which, under this part, means unless a documented justification says otherwise. Reagents made in-house have their production processes validated or verified.
Three records follow each material: receipt details including type, quantity, manufacturer, lot number, receipt date and expiration date; the verification result; and which lot went into which product.
Recovery is one sentence, and it is the earliest step
The recovery section covers the moment cells or tissue are taken. It is a single sentence and it is written as an outcome, not a method.
An establishment that recovers must do so in a way that does not cause contamination or cross-contamination during recovery, or otherwise increase the risk of disease transmission through use of the product.
No technique is prescribed. The obligation is to the result, which puts the burden on the establishment to show its method achieves it.
Storage, and the expiration date as a derived number
Storage areas and stock rooms have to be controlled to prevent two specific things: mix-ups, contamination and cross-contamination, and a product being improperly made available for distribution.
Products are stored at an appropriate temperature. Acceptable temperature limits are established for each step of manufacturing, to inhibit the growth of infectious agents.
Temperatures are maintained and recorded, and the recorded temperatures are periodically reviewed to confirm they stayed within limits. Where proper storage conditions are not met, corrective action is taken and documented.
An expiration date, where appropriate, is assigned from four named factors: the product type, the processing including the method of preservation, the storage conditions, and the packaging. It is an output of those inputs rather than a marketing choice.
What a reader can do with this
The useful move is to treat a processing claim as a claim about a validated process, and ask what it was validated against.
A firm that says a step inactivates pathogens is making the representation this rule names. The section requires a fully verified or validated basis for it, with dated, signed documentation behind the validation.
The same logic applies to a storage instruction and an expiration date. Both are supposed to be derived from stated factors and supported by recorded temperatures, not asserted.
None of this is published. These are internal records available to an inspector, so what a reader gets is a better question rather than an answer. Whether any particular firm holds these records is not something visible from a product page.
Key takeaways
- A written claim that processing reduces disease risk must rest on a fully verified or validated process.
- Validation is triggered when inspection and testing cannot fully verify the processing result.
- A process change requires verification or validation, prior approval by a responsible person, and communication to staff.
- Equipment used for inspection, measuring or testing must be capable of producing valid results.
- Maintenance and calibration records must be displayed on or near the equipment or otherwise readily available.
- An expiration date is derived from product type, processing, storage conditions and packaging.
Frequently asked questions
When does a tissue process have to be validated?
When the results of processing cannot be fully verified by subsequent inspection and tests. In that case the process must be validated and approved according to established procedures, with the validation activities and results documented, including the date and signature of the individual approving the validation.
What has to happen before a process change is made?
Three things. The change must be verified or validated to ensure it does not create an adverse impact elsewhere in the operation. It must be approved before implementation by a responsible person with appropriate knowledge and background. And approved changes must be communicated to the appropriate personnel in a timely manner.
Does a sterility or pathogen-inactivation claim need anything behind it?
Yes. The regulation covers any written representation that processing methods reduce the risk of transmission of communicable disease. That includes a representation of sterility or pathogen inactivation. Such a representation must be based on a fully verified or validated process.
How is an expiration date set for a tissue product?
Where appropriate, it is assigned based on four factors the regulation names: the product type, the processing including the method of preservation, the storage conditions, and the packaging. The same section requires acceptable temperature limits at each manufacturing step, recorded temperatures, and periodic review of those records.
Are incoming reagents tested by the manufacturer?
Not necessarily by them. Supplies and reagents cannot be used until verified against specifications, but the verification may be performed by the establishment that uses the material or by the vendor. Where the vendor does it, the record retained is a certificate of analysis from the vendor rather than an in-house test result.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- 21 CFR 1271.200, Equipment — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.210, Supplies and reagents — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.215, Recovery — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.225, Process changes — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.230, Process validation — Electronic Code of Federal Regulations, title 21, August 2026
- 21 CFR 1271.260, Storage — Electronic Code of Federal Regulations, title 21, August 2026